Sun Life Financial

L'entreprise

Sun Life spans individual insurance, a large asset-management arm (MFS Investment Management and SLC Management), Canadian and U.S. group benefits (including DentaQuest dental), and a growing Asia business.

The asset-management and group-benefits mix makes it more fee-oriented and capital-light than a pure life insurer.

Les avantages concurrentiels

A diversified, partly capital-light model — asset management and group benefits add stable fee streams to the insurance base.

MFS is a scaled, profitable global asset manager.

Aperçu financier

Période déclarée la plus récente : Q1 FY2026 (ended March 31, 2026). Les chiffres reflètent la date de révision — confirmez les chiffres actuels avant d'agir.

Rendement du flux de trésorerie disponible et croissance durable

Rendement des bénéfices : ≈4.6%≈ earnings yield (trailing P/E ~21.7)

As with any insurer, free cash flow isn't the right yardstick — Sun Life is measured on underlying ROE, underlying EPS growth and dividend coverage.

Its underlying ROE of 18.6% is among the best in the sector, and the fee-heavy asset-management/group-benefits mix makes those returns less capital-intensive to sustain.

Sustainable growth: mid-single-digit-plus underlying EPS growth from asset management, group benefits and Asia, supported by regular dividend increases.

Voir le classement complet du rendement des bénéfices →

Valorisation et points à surveiller

Sun Life is judged on underlying earnings and ROE, not free cash flow. It typically commands a premium to Manulife on its higher-quality, higher-ROE, more fee-based mix.

The gap between an 18.6% underlying ROE and an 8.2% reported ROE is the key thing to understand — the difference is market-driven noise, not operating weakness.

Dividende

Announced a 4% dividend increase (yield ~3.7%), backed by a high underlying ROE and diversified, partly fee-based earnings.

Risques et scénario baissier

• MFS asset-management net flows and AUM levels drive a big chunk of fee earnings.
• U.S. group/dental (DentaQuest) exposure to Medicaid redetermination and utilization.
• Interest-rate and equity-market sensitivity.
• Reported earnings can diverge sharply from underlying on market moves.

Faits récents

Q1 FY2026 underlying net income of C$1.05B and underlying EPS of C$1.89 (+4%), with an 18.6% underlying ROE and a 4% dividend increase.

Verdict

The higher-quality Canadian life-and-wealth name: a top-tier underlying ROE and a diversified, partly fee-based model. The bull case is durable high returns plus steady dividend growth; the bear case is MFS outflows and U.S. dental. Conviction: a quality core holding, usually priced for it.